21 – 30 of 67
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
- Contribution to journal › Article
- 2020
-
Mark
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
- Contribution to journal › Article
-
Mark
Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status
- Contribution to journal › Article
- 2018
-
Mark
Immune gene expression and response to chemotherapy in advanced breast cancer
- Contribution to journal › Article
-
Mark
A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis
- Contribution to journal › Article
-
Mark
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
- Contribution to journal › Article
-
Mark
Excess body weight, weight gain and obesity-related cancer risk in women in Norway : the Norwegian Women and Cancer study
- Contribution to journal › Article
- 2017
-
Mark
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer : A phase III, randomised, multicentre trial (Ovaresist)
- Contribution to journal › Article
-
Mark
Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
- Contribution to journal › Article
-
Mark
Towards gene-and gender-based risk estimates in Lynch syndrome; Age-specific incidences for 13 extra-colorectal cancer types
- Contribution to journal › Article
